ArticleCancer immunology, immunotherapy : CII2024

Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.

Thomas Eichholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.